Low Frequency of HLA-B*15:02 in Northwest China: Implications for Carbamazepine-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Screening Strategies

Xu Wang,1,2 Ping Yang,1,2 Feng Rao,3 Longnan Wang,3 Fenglin Mou,3 Huimei Zhang,1,2 QiuYan Chen,3 Zheng Yin,3 Yanzi Jing,1,2 Qiang Liu,1,2 Xianrui Xu,1,2 Qing Zhang1,21Department of Neurology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, People’s Republic of China; 2Ningxia Key Laboratory of Cerebrocranial Diseases, Incubation Base of National Key Laboratory, Ningxia Medical University, Yinchuan, Ningxia, People’s Republic of China; 3First Clinical Medical College, Ningxia Medical University, Yinchuan, Ningxia, People’s Republic of ChinaCorrespondence: Qing Zhang, Email [email protected] Xianrui Xu, Email [email protected]: HLA-B*15:02 is an important genetic marker for predicting carbamazepine (CBZ)-induced Stevens-Johnson Syndrome (SJS)/Toxic Epidermal Necrolysis (TEN) in Asian populations. This descriptive pooled analysis aimed to characterize HLA-B*15:02 distribution in Northwest China and inform regional screening strategies.Methods: We genotyped HLA-B*15:02 via next-generation sequencing (NGS) in 98 healthy volunteers from Ningxia, and combined these data with 11 previously published studies (total N=3400) from Northwest China. Weighted means, medians, and interquartile ranges (IQR) were calculated by region and ethnicity, with Pearson’s chi‑square tests for group comparisons (significance threshold: P < 0.05).Results: The overall HLA-B*15:02 frequency was 1.81% (range: 0.00%– 3.30%; IQR: 0.24– 1.97%). Regional weighted frequencies were 2.12% (Qinghai), 1.98% (Shaanxi), 1.02% (Ningxia), and 0.38% (Xinjiang); ethnic frequencies ranged from 0% (Kazakh) to 2.28% (Hui). No significant regional (χ2 = 7.60, P = 0.055) or ethnic (χ2 = 7.35, P = 0.119) differences were observed, nor was there a significant difference between Han and other ethnic groups (P = 0.074).Conclusion: The overall frequency of HLA-B*15:02 in Northwest China is 1.81%, substantially lower than in South China, suggesting a lower expected yield of routine screening in this region.Keywords: HLA-B*15:02, distribution frequency, Northwest China, carbamazepine

Authors

Publication Details

Journal
Dove Medical Press (Taylor and Francis Group)
Published
2026-08-25
Primary Topic
Drug-Induced Adverse Reactions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Low Frequency of HLA-B*15:02 in Northwest China: Implications for Carbamazepine-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Screening Strategies

Zheng Yin, Qiuyan Chen, Fenglin Mou, Yanzi Jing et al.
Dove Medical Press (Taylor and Francis Group)
Drug-Induced Adverse Reactions
article

Low Frequency of HLA-B*15:02 in Northwest China: Implications for Carbamazepine-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Screening Strategies

Zheng Yin, Qiuyan Chen, Fenglin Mou, Yanzi Jing, Longnan Wang, Huimei Zhang, Feng Rao, Qing Zhang, Qiang Liu, Xianrui Xu, Ping Yang, Xu Wang
article en

Abstract

Xu Wang,1,2 Ping Yang,1,2 Feng Rao,3 Longnan Wang,3 Fenglin Mou,3 Huimei Zhang,1,2 QiuYan Chen,3 Zheng Yin,3 Yanzi Jing,1,2 Qiang Liu,1,2 Xianrui Xu,1,2 Qing Zhang1,21Department of Neurology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, People’s Republic of China; 2Ningxia Key Laboratory of Cerebrocranial Diseases, Incubation Base of National Key Laboratory, Ningxia Medical University, Yinchuan, Ningxia, People’s Republic of China; 3First Clinical Medical College, Ningxia Medical University, Yinchuan, Ningxia, People’s Republic of ChinaCorrespondence: Qing Zhang, Email [email protected] Xianrui Xu, Email [email protected]: HLA-B*15:02 is an important genetic marker for predicting carbamazepine (CBZ)-induced Stevens-Johnson Syndrome (SJS)/Toxic Epidermal Necrolysis (TEN) in Asian populations. This descriptive pooled analysis aimed to characterize HLA-B*15:02 distribution in Northwest China and inform regional screening strategies.Methods: We genotyped HLA-B*15:02 via next-generation sequencing (NGS) in 98 healthy volunteers from Ningxia, and combined these data with 11 previously published studies (total N=3400) from Northwest China. Weighted means, medians, and interquartile ranges (IQR) were calculated by region and ethnicity, with Pearson’s chi‑square tests for group comparisons (significance threshold: P < 0.05).Results: The overall HLA-B*15:02 frequency was 1.81% (range: 0.00%– 3.30%; IQR: 0.24– 1.97%). Regional weighted frequencies were 2.12% (Qinghai), 1.98% (Shaanxi), 1.02% (Ningxia), and 0.38% (Xinjiang); ethnic frequencies ranged from 0% (Kazakh) to 2.28% (Hui). No significant regional (χ2 = 7.60, P = 0.055) or ethnic (χ2 = 7.35, P = 0.119) differences were observed, nor was there a significant difference between Han and other ethnic groups (P = 0.074).Conclusion: The overall frequency of HLA-B*15:02 in Northwest China is 1.81%, substantially lower than in South China, suggesting a lower expected yield of routine screening in this region.Keywords: HLA-B*15:02, distribution frequency, Northwest China, carbamazepine

Dove Medical Press (Taylor and Francis Group)
Openalex Percentile: Top 11%
Drug-Induced Adverse Reactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.